Fatty acids in cancer: Metabolic functions and potential treatment

[1]  T. Katagiri,et al.  Blue light induces apoptosis and autophagy by promoting ROS‐mediated mitochondrial dysfunction in synovial sarcoma , 2023, Cancer medicine.

[2]  Ping-Tzu Chen,et al.  Tetrahydrocurcumin regulates the tumor immune microenvironment to inhibit breast cancer proliferation and metastasis via the CYP1A1/NF-κB signaling pathway , 2023, Cancer Cell International.

[3]  Y. Ke,et al.  Molecular mechanisms on how FABP5 inhibitors promote apoptosis‐induction sensitivity of prostate cancer cells , 2023, Cell biology international.

[4]  S. Tsai,et al.  Gold Nanoparticles Enhancing Generation of ROS for Cs-137 Radiotherapy , 2022, Nanoscale research letters.

[5]  Juan Wang,et al.  c-Jun phosphorylated by JNK is required for protecting Gli2 from proteasomal-ubiquitin degradation by PGE2-JNK signaling axis. , 2022, Biochimica et biophysica acta. Molecular cell research.

[6]  Michael R Hamblin,et al.  Tumor-derived exosomal non-coding RNAs as diagnostic biomarkers in cancer , 2022, Cellular and Molecular Life Sciences.

[7]  S. Welford,et al.  Fatty acid metabolism reprogramming in ccRCC: mechanisms and potential targets , 2022, Nature Reviews Urology.

[8]  S. Benitah,et al.  The role of lipids in cancer progression and metastasis. , 2022, Cell metabolism.

[9]  A. Giannoudis,et al.  The role of CPT1A as a biomarker of breast cancer progression: a bioinformatic approach , 2022, Scientific Reports.

[10]  M. Colombo,et al.  SCD5-dependent inhibition of SPARC secretion hampers metastatic spreading and favors host immunity in a TNBC murine model , 2022, Oncogene.

[11]  Jilin Li,et al.  Fatty acid binding protein 5 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by degradation of Krüppel-like factor 9 mediated by miR-889-5p via cAMP-response element binding protein , 2022, Cancer biology & therapy.

[12]  Chun-Bing Chen,et al.  Cancer-Derived Extracellular Vesicles as Biomarkers for Cutaneous Squamous Cell Carcinoma: A Systematic Review , 2022, Cancers.

[13]  M. Kolonin,et al.  Fatty acid translocase: a culprit of lipid metabolism dysfunction in disease , 2022, Immunometabolism (Cobham (Surrey, England)).

[14]  C. Ishioka,et al.  Inhibition of stearoyl-CoA desaturase 1 (SCD1) enhances the antitumor T cell response through regulating β-catenin signaling in cancer cells and ER stress in T cells and synergizes with anti-PD-1 antibody , 2022, Journal for ImmunoTherapy of Cancer.

[15]  Jieqing Li,et al.  Prevention of taxane-associated acute pain syndrome with etoricoxib for patients with breast cancer: A phase II randomised trial. , 2022, European journal of cancer.

[16]  C. Garrido,et al.  Lipidomic profiling of exosomes from colorectal cancer cells and patients reveals potential biomarkers , 2022, Molecular oncology.

[17]  Hui Zhang,et al.  ELOVL2 restrains cell proliferation, migration, and invasion of prostate cancer via regulation of the tumor suppressor INPP4B. , 2022, Cellular signalling.

[18]  Wei Wang,et al.  FASN promotes lymph node metastasis in cervical cancer via cholesterol reprogramming and lymphangiogenesis , 2022, Cell Death & Disease.

[19]  D. Hong,et al.  Dietary influences on symptomatic and non-symptomatic toxicities during cancer treatment: A narrative review. , 2022, Cancer treatment reviews.

[20]  F. Finkernagel,et al.  Arachidonic acid, a clinically adverse mediator in the ovarian cancer microenvironment, impairs JAK‐STAT signaling in macrophages by perturbing lipid raft structures , 2022, Molecular oncology.

[21]  Peng-Ju Chen,et al.  Design, synthesis, and cytotoxic activities of isaindigotone derivatives as potential anti-gastric cancer agents , 2022, Journal of enzyme inhibition and medicinal chemistry.

[22]  Alissa M. Weaver,et al.  Extracellular Vesicles and Their Emerging Roles as Cellular Messengers in Endocrinology: An Endocrine Society Scientific Statement. , 2022, Endocrine reviews.

[23]  H. Pan,et al.  Highly Purified Eicosapentaenoic Acid Alleviates the Inflammatory Response and Oxidative Stress in Macrophages during Atherosclerosis via the miR-1a-3p/sFRP1/Wnt/PCP-JNK Pathway , 2022, Oxidative medicine and cellular longevity.

[24]  Aijun Wang,et al.  Fatty acid oxidation fuels glioblastoma radioresistance with CD47-mediated immune evasion , 2022, Nature Communications.

[25]  Casie Kubota,et al.  Targeting stearoyl-CoA desaturase in solid tumors. , 2022, Cancer research.

[26]  Jibo He,et al.  Acetyl-CoA Carboxylases and Diseases , 2022, Frontiers in Oncology.

[27]  S. Pakrashi,et al.  Quercetin Attenuates Copper-Induced Apoptotic Cell Death and Endoplasmic Reticulum Stress in SH-SY5Y Cells by Autophagic Modulation , 2022, Biological Trace Element Research.

[28]  Q. Ye,et al.  MicroRNA-377-3p inhibits hepatocellular carcinoma growth and metastasis through negative regulation of CPT1C-mediated fatty acid oxidation , 2022, Cancer & metabolism.

[29]  H. Nishiyama,et al.  ELOVL2 promotes cancer progression by inhibiting cell apoptosis in renal cell carcinoma , 2021, Oncology reports.

[30]  S. Yuan,et al.  Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma , 2021, Acta pharmaceutica Sinica. B.

[31]  A. Bode,et al.  Prostaglandin Pathways: Opportunities for Cancer Prevention and Therapy , 2021, Cancer research.

[32]  Hui Zheng,et al.  Differentially Expressed Genes in Clear Cell Renal Cell Carcinoma as a Potential Marker for Prognostic and Immune Signatures , 2021, Frontiers in Oncology.

[33]  M. Tavakoli-Yaraki,et al.  15-Lipoxygenase and its metabolites in the pathogenesis of breast cancer: A double-edged sword , 2021, Lipids in health and disease.

[34]  I. Fleming,et al.  Cytochrome P450-derived fatty acid epoxides and diols in angiogenesis and stem cell biology. , 2021, Pharmacology & therapeutics.

[35]  Jianbo Xiao,et al.  Effects of Arachidonic Acid Metabolites on Cardiovascular Health and Disease , 2021, International journal of molecular sciences.

[36]  M. V. Vander Heiden,et al.  Low glycaemic diets alter lipid metabolism to influence tumour growth , 2021, Nature.

[37]  H. You,et al.  Leukotriene B4 receptor-2 contributes to KRAS-driven lung tumor formation by promoting interleukin-6-mediated inflammation , 2021, Experimental & Molecular Medicine.

[38]  R. DuBois,et al.  Cyclooxygenases and Prostaglandins in Tumor Immunology and Microenvironment of Gastrointestinal Cancer. , 2021, Gastroenterology.

[39]  Yuan Fang,et al.  Integration of glucose and cardiolipin anabolism confers radiation resistance of HCC , 2021, Hepatology.

[40]  Chih-Yu Chen,et al.  Increased lipogenesis is critical for self‐renewal and growth of breast cancer stem cells: Impact of omega‐3 fatty acids , 2021, Stem cells.

[41]  Sajeli Begum Ahil,et al.  Review on target domains and natural compound‐based inhibitors of fatty acid synthase for anticancer drug discovery , 2021 .

[42]  L. Butler,et al.  Tumour fatty acid metabolism in the context of therapy resistance and obesity , 2021, Nature Reviews Cancer.

[43]  Jared L. Johnson,et al.  Dietary fructose improves intestinal cell survival and nutrient absorption , 2021, Nature.

[44]  Á. Lanas,et al.  Platelets induce free and phospholipid-esterified 12-hydroxyeicosatetraenoic acid generation in colon cancer cells by delivering 12-lipoxygenase , 2021, Journal of lipid research.

[45]  C. Denkert,et al.  Effect of Celecoxib vs Placebo as Adjuvant Therapy on Disease-Free Survival Among Patients With Breast Cancer: The REACT Randomized Clinical Trial. , 2021, JAMA oncology.

[46]  C. Pareek,et al.  Effects of Dietary n–3 and n–6 Polyunsaturated Fatty Acids in Inflammation and Cancerogenesis , 2021, International journal of molecular sciences.

[47]  A. Kozubík,et al.  Complex Alterations of Fatty Acid Metabolism and Phospholipidome Uncovered in Isolated Colon Cancer Epithelial Cells , 2021, International journal of molecular sciences.

[48]  S. Denmeade,et al.  Fatty Acid Synthesis in Prostate Cancer: Vulnerability or Epiphenomenon? , 2021, Cancer Research.

[49]  Zhihua Wen,et al.  RAD001 targeted HUVECs reverses 12‐lipoxygenase‐induced angiogenesis in oesophageal squamous cell carcinoma , 2021, Journal of cellular and molecular medicine.

[50]  O. Feron,et al.  Peroxidation of n-3 and n-6 polyunsaturated fatty acids in the acidic tumor environment leads to ferroptosis-mediated anticancer effects. , 2021, Cell metabolism.

[51]  J. Prieto,et al.  In Vitro Effects of Selective COX and LOX Inhibitors and Their Combinations with Antineoplastic Drugs in the Mouse Melanoma Cell Line B16F10 , 2021, International journal of molecular sciences.

[52]  Chen-Yu Zhang,et al.  Long Noncoding RNA CTD-2245E15.3 Promotes Anabolic Enzymes ACC1 and PC to Support Non–Small Cell Lung Cancer Growth , 2021, Cancer Research.

[53]  G. Barceló-Coblijn,et al.  Fatty Acid Unsaturation Degree of Plasma Exosomes in Colorectal Cancer Patients: A Promising Biomarker , 2021, International journal of molecular sciences.

[54]  J. Meyerhardt,et al.  Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial. , 2021, JAMA.

[55]  A. Brenner,et al.  First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors , 2021, EClinicalMedicine.

[56]  K. Koike,et al.  Lipid Metabolism in Oncology: Why It Matters, How to Research, and How to Treat , 2021, Cancers.

[57]  L. Butler,et al.  The diversity and breadth of cancer cell fatty acid metabolism , 2021, Cancer & metabolism.

[58]  L. Qin,et al.  Lipid metabolism in cancer progression and therapeutic strategies , 2020, MedComm.

[59]  J. Kench,et al.  Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition , 2020, Cancer Research.

[60]  Ryan D. Clay,et al.  PPARα Inhibition Overcomes Tumor-Derived Exosomal Lipid-Induced Dendritic Cell Dysfunction , 2020, Cell reports.

[61]  Hongyang Wang,et al.  ATP-citrate lyase regulates stemness and metastasis in hepatocellular carcinoma via the Wnt/β-catenin signaling pathway. , 2020, Hepatobiliary & pancreatic diseases international : HBPD INT.

[62]  S. Rockson,et al.  Leukotrienes in Tumor-Associated Inflammation , 2020, Frontiers in Pharmacology.

[63]  D. Klionsky,et al.  Ferroptosis: machinery and regulation , 2020, Autophagy.

[64]  M. Rafat,et al.  Lipids in the tumor microenvironment: From cancer progression to treatment. , 2020, Progress in lipid research.

[65]  M. Althubiti,et al.  Evaluation of the Diagnostic and Predicative Values of 8-Iso-Prostaglandin F2α as a Biomarker of Breast Cancer , 2020, Oncology Research and Treatment.

[66]  Galina A. Erikson,et al.  Tuft Cells Inhibit Pancreatic Tumorigenesis in Mice by Producing Prostaglandin D2. , 2020, Gastroenterology.

[67]  M. Loda,et al.  Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention. , 2020, Advanced drug delivery reviews.

[68]  C. Muller,et al.  Drilling for Oil: Tumor-Surrounding Adipocytes Fueling Cancer. , 2020, Trends in cancer.

[69]  Ying-bo Li,et al.  Eicosapentaenoic acid’s metabolism of 15-LOX-1 promotes the expression of miR-101 thus inhibits Cox2 pathway in colon cancer , 2020, OncoTargets and therapy.

[70]  B. Stockwell,et al.  Emerging Mechanisms and Disease Relevance of Ferroptosis. , 2020, Trends in cell biology.

[71]  K. Vousden,et al.  Dietary Approaches to Cancer Therapy. , 2020, Cancer cell.

[72]  B. Faubert,et al.  Metabolic reprogramming and cancer progression , 2020, Science.

[73]  Yi-chun Chen,et al.  FABP7 is a potential biomarker to predict response to neoadjuvant chemotherapy for breast cancer , 2020, Cancer Cell International.

[74]  J. Ajani,et al.  The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression , 2020, Cell Research.

[75]  B. Stockwell,et al.  Radiation-Induced Lipid Peroxidation Triggers Ferroptosis and Synergizes with Ferroptosis Inducers. , 2020, ACS chemical biology.

[76]  M. L. Curri,et al.  Exosomes for Diagnosis and Therapy in Gastrointestinal Cancers , 2020, International journal of molecular sciences.

[77]  E. Yilmaz,et al.  Untargeted Multi-Omic Analysis of Colorectal Cancer-Specific Exosomes Reveals Joint Pathways of Colorectal Cancer in both Clinical Samples and Cell Culture. , 2020, Cancer letters.

[78]  S. Fan,et al.  High COX‐2 expression in cancer‐associated fibiroblasts contributes to poor survival and promotes migration and invasiveness in nasopharyngeal carcinoma , 2019, Molecular carcinogenesis.

[79]  H. Tsukamoto,et al.  Stearoyl-CoA desaturase and tumorigenesis. , 2019, Chemico-biological interactions.

[80]  A. C. Gasparovic,et al.  Phospholipids and cholesterol: Inducers of cancer multidrug resistance and therapeutic targets. , 2019, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[81]  S. Nowicki,et al.  GPR75 receptor mediates 20-HETE-signaling and metastatic features of androgen-insensitive prostate cancer cells. , 2019, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[82]  Siwei Wang,et al.  Four transcription profile–based models identify novel prognostic signatures in oesophageal cancer , 2019, Journal of cellular and molecular medicine.

[83]  L. Trotman,et al.  Docetaxel/cabazitaxel and fatty acid binding protein 5 inhibitors produce synergistic inhibition of prostate cancer growth , 2019, The Prostate.

[84]  Xi Zhang,et al.  Identification of hub genes and key pathways associated with the progression of gynecological cancer , 2019, Oncology letters.

[85]  Jeng-Jong Hwang,et al.  Fatty Acid Inhibition Sensitizes Androgen-Dependent and -Independent Prostate Cancer to Radiotherapy via FASN/NF-κB Pathway , 2019, Scientific Reports.

[86]  Li Zhao,et al.  ACLY facilitates colon cancer cell metastasis by CTNNB1 , 2019, Journal of Experimental & Clinical Cancer Research.

[87]  Wei Zhao,et al.  Synthesis and anti-cancer activity of ND-646 and its derivatives as acetyl-CoA carboxylase 1 inhibitors. , 2019, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[88]  A. Joubert,et al.  Warburg effect and its role in tumourigenesis , 2019, Archives of Pharmacal Research.

[89]  T. Curran,et al.  Leukotriene Synthesis Is Critical for Medulloblastoma Progression , 2019, Clinical Cancer Research.

[90]  M. Matin,et al.  Stylosin and some of its synthetic derivatives induce apoptosis in prostate cancer cells as 15-lipoxygenase enzyme inhibitors , 2019, Naunyn-Schmiedeberg's Archives of Pharmacology.

[91]  C. Thompson,et al.  Metabolic regulation of cell growth and proliferation , 2019, Nature Reviews Molecular Cell Biology.

[92]  J. Swinnen,et al.  Lipid metabolism in cancer cells under metabolic stress , 2019, British Journal of Cancer.

[93]  G. Wang,et al.  Inhibition of LTA4H by bestatin in human and mouse colorectal cancer , 2019, EBioMedicine.

[94]  Ben S. Wittner,et al.  COX-2 mediates tumor-stromal prolactin signaling to initiate tumorigenesis , 2019, Proceedings of the National Academy of Sciences.

[95]  Zhenggang Zhu,et al.  CD36 mediates palmitate acid-induced metastasis of gastric cancer via AKT/GSK-3β/β-catenin pathway , 2019, Journal of experimental & clinical cancer research : CR.

[96]  B. Faubert,et al.  Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity , 2019, Nature.

[97]  P. Muti,et al.  Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma. , 2019, Cell metabolism.

[98]  Zhe Zhang,et al.  Inhibition of stearoyl CoA desaturase‐1 activity suppresses tumour progression and improves prognosis in human bladder cancer , 2018, Journal of cellular and molecular medicine.

[99]  F. Torti,et al.  Steroyl-CoA Desaturase 1 (SCD1) protects ovarian cancer cells from ferroptotic cell death. , 2019, Cancer research.

[100]  M. Touvier,et al.  Saturated, mono- and polyunsaturated fatty acid intake and cancer risk: results from the French prospective cohort NutriNet-Santé , 2019, European Journal of Nutrition.

[101]  L. Fattore,et al.  Inhibition of Stearoyl-CoA desaturase 1 reverts BRAF and MEK inhibition-induced selection of cancer stem cells in BRAF-mutated melanoma , 2018, Journal of experimental & clinical cancer research : CR.

[102]  K. Ghaedi,et al.  Diverse roles of fatty acid binding proteins (FABPs) in development and pathogenesis of cancers. , 2018, Gene.

[103]  S. Braig.  Chemical genetics in tumor lipogenesis. , 2018, Biotechnology advances.

[104]  A. Colquhoun,et al.  Eicosanoids and cancer , 2018, Clinics.

[105]  G. Ren,et al.  Utilization of adipocyte-derived lipids and enhanced intracellular trafficking of fatty acids contribute to breast cancer progression , 2018, Cell Communication and Signaling.

[106]  S. Chien,et al.  Suspension state promotes metastasis of breast cancer cells by up-regulating cyclooxygenase-2 , 2018, Theranostics.

[107]  I. Fleming,et al.  Angiogenesis and vascular stability in eicosanoids and cancer , 2018, Cancer and Metastasis Reviews.

[108]  D. Xie,et al.  FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma , 2018, Cancer medicine.

[109]  Giuseppe Infusini,et al.  Discovery and Validation of Novel Protein Biomarkers in Ovarian Cancer Patient Urine , 2018, Proteomics. Clinical applications.

[110]  A. Shiau,et al.  Elovl6 is a negative clinical predictor for liver cancer and knockdown of Elovl6 reduces murine liver cancer progression , 2018, Scientific Reports.

[111]  N. deSouza,et al.  The effect of FASN inhibition on the growth and metabolism of a cisplatin‐resistant ovarian carcinoma model , 2018, International journal of cancer.

[112]  Yu-Ying He,et al.  Knockdown delta-5-desaturase in breast cancer cells that overexpress COX-2 results in inhibition of growth, migration and invasion via a dihomo-γ-linolenic acid peroxidation dependent mechanism , 2018, BMC Cancer.

[113]  J. Onuchic,et al.  Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapy , 2018, Theranostics.

[114]  F. Berrino,et al.  Diet and supplements in cancer prevention and treatment: Clinical evidences and future perspectives. , 2018, Critical reviews in oncology/hematology.

[115]  Hua Yu,et al.  JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance. , 2018, Cell metabolism.

[116]  T. Cotter,et al.  Seminars in Cell & Developmental Biology , 2018 .

[117]  Jung-Hye Choi,et al.  Iloprost, a prostacyclin analog, inhibits the invasion of ovarian cancer cells by downregulating matrix metallopeptidase-2 (MMP-2) through the IP-dependent pathway. , 2018, Prostaglandins & other lipid mediators.

[118]  M. Stockler,et al.  A distinct plasma lipid signature associated with poor prognosis in castration‐resistant prostate cancer , 2017, International Journal of Cancer.

[119]  Yu Bai,et al.  A plasma lipidomics strategy reveals perturbed lipid metabolic pathways and potential lipid biomarkers of human colorectal cancer. , 2017, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[120]  V. Jala,et al.  The yin and yang of leukotriene B4 mediated inflammation in cancer. , 2017, Seminars in immunology.

[121]  J. Haeggström,et al.  Biosynthesis of leukotriene B4. , 2017, Seminars in immunology.

[122]  J. Menéndez,et al.  Fatty acid synthase (FASN) as a therapeutic target in breast cancer , 2017, Expert opinion on therapeutic targets.

[123]  Yinsong Wang,et al.  Combination therapy of PKCζ and COX-2 inhibitors synergistically suppress melanoma metastasis , 2017, Journal of experimental & clinical cancer research : CR.

[124]  Pengyuan Yang,et al.  Functional lipidomics: Palmitic acid impairs hepatocellular carcinoma development by modulating membrane fluidity and glucose metabolism , 2017, Hepatology.

[125]  E. Cuyás,et al.  Clinical and therapeutic relevance of the metabolic oncogene fatty acid synthase in HER2+ breast cancer. , 2017, Histology and histopathology.

[126]  R. Chapkin,et al.  Dietary fat and fiber interactively modulate apoptosis and mitochondrial bioenergetic profiles in mouse colon in a site-specific manner , 2017, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[127]  Stuart L. Schreiber,et al.  Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition , 2017, Nature.

[128]  O. Sansom,et al.  Modulating the therapeutic response of tumours to dietary serine and glycine starvation , 2017, Nature.

[129]  Yu Xia,et al.  Lipid Desaturation Is a Metabolic Marker and Therapeutic Target of Ovarian Cancer Stem Cells. , 2017, Cell stem cell.

[130]  Peixuan Guo,et al.  Inhibition of cancer migration and invasion by knocking down delta-5-desaturase in COX-2 overexpressed cancer cells , 2017, Redox biology.

[131]  A. Avan,et al.  Circulating exosomes and exosomal microRNAs as biomarkers in gastrointestinal cancer , 2016, Cancer Gene Therapy.

[132]  Camille Stephan-Otto Attolini,et al.  Targeting metastasis-initiating cells through the fatty acid receptor CD36 , 2016, Nature.

[133]  B. Patil,et al.  Rapidly cycling Lgr5+ stem cells are exquisitely sensitive to extrinsic dietary factors that modulate colon cancer risk , 2016, Cell Death & Disease.

[134]  M. Kreft,et al.  Comparative lipidomic study of urothelial cancer models: association with urothelial cancer cell invasiveness. , 2016, Molecular bioSystems.

[135]  M. Johansson,et al.  Metastasis Stimulation by Hypoxia and Acidosis-Induced Extracellular Lipid Uptake Is Mediated by Proteoglycan-Dependent Endocytosis. , 2016, Cancer research.

[136]  B. Stockwell,et al.  Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis , 2016, Proceedings of the National Academy of Sciences.

[137]  B. Guo,et al.  Knockdown delta-5-desaturase promotes the formation of a novel free radical byproduct from COX-catalyzed ω-6 peroxidation to induce apoptosis and sensitize pancreatic cancer cells to chemotherapy drugs. , 2016, Free radical biology & medicine.

[138]  Yuanying Chen,et al.  Fatty acid metabolism and cancer development , 2016 .

[139]  E. White,et al.  Mitochondria and Cancer. , 2016, Molecular cell.

[140]  Yu-Huei Liu,et al.  Liver fatty acid-binding protein (L-FABP) promotes cellular angiogenesis and migration in hepatocellular carcinoma , 2016, Oncotarget.

[141]  N. Casals,et al.  Carnitine palmitoyltransferase 1C: From cognition to cancer. , 2016, Progress in lipid research.

[142]  A. Houston,et al.  Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets? , 2015, British journal of pharmacology.

[143]  L. Roberts,et al.  Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma , 2015, Scientific Reports.

[144]  J. Käs,et al.  Cell membrane softening in human breast and cervical cancer cells , 2015 .

[145]  N. Youssef,et al.  Combined use of COX-1 and VEGF immunohistochemistry refines the histopathologic prognosis of renal cell carcinoma. , 2015, International journal of clinical and experimental pathology.

[146]  Yu-Jen Chao,et al.  Polyunsaturated fatty acids incorporation into cardiolipin in H9c2 cardiac myoblast. , 2015, The Journal of nutritional biochemistry.

[147]  F. Mottaghy,et al.  Fatty acid synthase overexpression: target for therapy and reversal of chemoresistance in ovarian cancer , 2015, Journal of Translational Medicine.

[148]  Feng Wang,et al.  Four types of fatty acids exert differential impact on pancreatic cancer growth. , 2015, Cancer letters.

[149]  U. Das,et al.  Growth Inhibitory Effect of Polyunsaturated Fatty Acids (PUFAs) on Colon Cancer Cells via Their Growth Inhibitory Metabolites and Fatty Acid Composition Changes , 2015, PloS one.

[150]  X. Ren,et al.  Perhexiline promotes HER3 ablation through receptor internalization and inhibits tumor growth , 2015, Breast Cancer Research.

[151]  Xiaolong Wei,et al.  Elevated 14,15- epoxyeicosatrienoic acid by increasing of cytochrome P450 2C8, 2C9 and 2J2 and decreasing of soluble epoxide hydrolase associated with aggressiveness of human breast cancer , 2014, BMC Cancer.

[152]  Leah Rider,et al.  Lipid Catabolism via CPT1 as a Therapeutic Target for Prostate Cancer , 2014, Molecular Cancer Therapeutics.

[153]  W. Mustain,et al.  Cancer cell-associated fatty acid synthase activates endothelial cells and promotes angiogenesis in colorectal cancer. , 2014, Carcinogenesis.

[154]  Mohamed Abdelwahab Alassal,et al.  Cytochrome P450-isoenzyme 1A1 in susceptibility to tobacco-related lung cancer , 2014, Asian cardiovascular & thoracic annals.

[155]  M. Imoto,et al.  5-Lipoxygenase and cysteinyl leukotriene receptor 1 regulate epidermal growth factor-induced cell migration through Tiam1 upregulation and Rac1 activation , 2014, Cancer science.

[156]  R. Pink,et al.  Routes and mechanisms of extracellular vesicle uptake , 2014, Journal of extracellular vesicles.

[157]  Hua Li,et al.  Mechanism of fatty acid synthase in drug tolerance related to epithelial-mesenchymal transition of breast cancer. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[158]  Ajay Kumar,et al.  Tumor growth retardation and chemosensitizing action of fatty acid synthase inhibitor orlistat on T cell lymphoma: implication of reconstituted tumor microenvironment and multidrug resistance phenotype. , 2014, Biochimica et biophysica acta.

[159]  Robert V Farese,et al.  Cellular fatty acid metabolism and cancer. , 2013, Cell metabolism.

[160]  T. Balla,et al.  Phosphoinositides: tiny lipids with giant impact on cell regulation. , 2013, Physiological reviews.

[161]  R. Matsunuma,et al.  Human Breast Cancer Tissues Contain Abundant Phosphatidylcholine(36∶1) with High Stearoyl-CoA Desaturase-1 Expression , 2013, PloS one.

[162]  S. Hwang,et al.  Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis , 2013, Proceedings of the National Academy of Sciences.

[163]  H. Hurwitz,et al.  A phase I study of ABT-510 plus bevacizumab in advanced solid tumors , 2013, Cancer medicine.

[164]  R. Coletta,et al.  The fatty acid synthase inhibitor orlistat reduces experimental metastases and angiogenesis in B16-F10 melanomas , 2012, British Journal of Cancer.

[165]  Ximing Xu,et al.  Inhibition of 12-lipoxygenase reduces proliferation and induces apoptosis of hepatocellular carcinoma cells in vitro and in vivo. , 2012, Hepatobiliary & pancreatic diseases international : HBPD INT.

[166]  R. Deberardinis,et al.  Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us? , 2012, Cell.

[167]  Vito Pistoia,et al.  Fasting Cycles Retard Growth of Tumors and Sensitize a Range of Cancer Cell Types to Chemotherapy , 2012, Science Translational Medicine.

[168]  A. Kihara,et al.  Biochemical characterization of the very long‐chain fatty acid elongase ELOVL7 , 2011, FEBS letters.

[169]  J. Rolin,et al.  Effects of Lysophospholipids on Tumor Microenvironment , 2011, Cancer Microenvironment.

[170]  E. Schuetz,et al.  CYP3A4 Mediates Growth of Estrogen Receptor-positive Breast Cancer Cells in Part by Inducing Nuclear Translocation of Phospho-Stat3 through Biosynthesis of (±)-14,15-Epoxyeicosatrienoic Acid (EET)* , 2011, The Journal of Biological Chemistry.

[171]  Carol L. Williams,et al.  Inhibition of carcinoma cell motility by epoxyeicosatrienoic acid (EET) antagonists , 2010, Cancer science.

[172]  Sebastian Munck,et al.  De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation. , 2010, Cancer research.

[173]  S. Heys,et al.  Profiling the expression of cytochrome P450 in breast cancer , 2010, Histopathology.

[174]  T. Oda,et al.  Fatty acid synthase inhibitor cerulenin suppresses liver metastasis of colon cancer in mice , 2010, Cancer science.

[175]  G. Pond,et al.  A phase III randomized trial of the timing of meloxicam with iodine-125 prostate brachytherapy. , 2010, International journal of radiation oncology, biology, physics.

[176]  R. DuBois,et al.  Eicosanoids and cancer , 2010, Nature Reviews Cancer.

[177]  K. Kaluarachchi,et al.  Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction. , 2010, The Journal of clinical investigation.

[178]  Sreeparna Banerjee,et al.  15‐Lipoxygenase‐1 expression suppresses the invasive properties of colorectal carcinoma cell lines HCT‐116 and HT‐29 , 2009, Cancer science.

[179]  N. Yonemitsu,et al.  5-lipoxygenase pathway promotes cell proliferation in human glioma cell lines. , 2009, Clinical Neuropathology.

[180]  Yusuke Nakamura,et al.  Novel lipogenic enzyme ELOVL7 is involved in prostate cancer growth through saturated long-chain fatty acid metabolism. , 2009, Cancer research.

[181]  S. Nonogaki,et al.  Leukotriene B4 Creates a Favorable Microenvironment for Murine Melanoma Growth , 2009, Molecular Cancer Research.

[182]  Zhi Wang,et al.  Topical chemoprevention of skin cancer in mice, using combined inhibitors of 5-lipoxygenase and cyclo-oxygenase-2 , 2009, The Journal of Laryngology & Otology.

[183]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[184]  Heather R. Roberts,et al.  The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. , 2009, Carcinogenesis.

[185]  D. Jump.  Mammalian fatty acid elongases. , 2009, Methods in molecular biology.

[186]  A. Horiguchi,et al.  Pharmacological inhibitor of fatty acid synthase suppresses growth and invasiveness of renal cancer cells. , 2008, The Journal of urology.

[187]  Carl Morrison,et al.  Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[188]  J. Swinnen,et al.  Chemical inhibition of acetyl-CoA carboxylase induces growth arrest and cytotoxicity selectively in cancer cells. , 2007, Cancer research.

[189]  A. C. Williams,et al.  Prostaglandin F2α stimulates motility and invasion in colorectal tumor cells , 2007 .

[190]  M. Hersberger,et al.  The two faces of the 15-lipoxygenase in atherosclerosis. , 2007, Prostaglandins, leukotrienes, and essential fatty acids.

[191]  M. Kreutzer,et al.  Specific components of prostanoid-signaling pathways are present in non-small cell lung cancer cells. , 2007, Oncology reports.

[192]  D. Chalbos,et al.  Increased expression of fatty acid synthase and progesterone receptor in early steps of human mammary carcinogenesis , 2007, International journal of cancer.

[193]  L. Dwyer-Nield,et al.  Prostaglandin E2 receptor subtype 2 (EP2) null mice are protected against murine lung tumorigenesis. , 2006, Anticancer research.

[194]  R. Kerbel,et al.  Metronomic Low-Dose Chemotherapy Boosts CD95-Dependent Antiangiogenic Effect of the Thrombospondin Peptide ABT-510: A Complementation Antiangiogenic Strategy , 2005, Clinical Cancer Research.

[195]  R. DuBois,et al.  PROSTAGLANDINS AND CANCER , 2005, Gut.

[196]  P. Stehle,et al.  Preoperative Oral Supplementation with Long-Chain Ω-3 Fatty Acids Beneficially Alters Phospholipid Fatty Acid Patterns in Liver, Gut Mucosa, and Tumor Tissue. , 2005, JPEN. Journal of parenteral and enteral nutrition.

[197]  D. Zeldin,et al.  Cytochrome P450 2J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors. , 2005, Cancer research.

[198]  R. DuBois,et al.  The role of prostaglandins and other eicosanoids in the gastrointestinal tract. , 2005, Gastroenterology.

[199]  B. Wong,et al.  Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke. , 2005, Carcinogenesis.

[200]  V. Baracos,et al.  n-3 Polyunsaturated fatty acids throughout the cancer trajectory: influence on disease incidence, progression, response to therapy and cancer-associated cachexia , 2004, Nutrition Research Reviews.

[201]  D. Beer,et al.  Overexpression of 5-Lipoxygenase in Rat and Human Esophageal Adenocarcinoma and Inhibitory Effects of Zileuton and Celecoxib on Carcinogenesis , 2004, Clinical Cancer Research.

[202]  H. Guski,et al.  Effects of Celebrex and Zyflo on liver metastasis and lipidperoxidation in pancreatic cancer in Syrian hamsters , 2001, Clinical & Experimental Metastasis.

[203]  G. Landberg,et al.  Expression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomas. , 2003, Gastroenterology.

[204]  R. Carroll,et al.  Fish oil increases mitochondrial phospholipid unsaturation, upregulating reactive oxygen species and apoptosis in rat colonocytes. , 2002, Carcinogenesis.

[205]  T. Eling,et al.  Opposing Effects of 15-Lipoxygenase-1 and -2 Metabolites on MAPK Signaling in Prostate , 2002, The Journal of Biological Chemistry.

[206]  M. Sentjurc,et al.  Cell membrane fluidity and prognosis of lung cancer. , 2002, The Annals of thoracic surgery.

[207]  J. Lupton,et al.  Dietary n−3 PUFA alter colonocyte mitochondrial membrane composition and function , 2002, Lipids.

[208]  J. Masferrer,et al.  Selective inhibition of Δ-6 desaturase impedes intestinal tumorigenesis , 2002 .

[209]  D. Grignon,et al.  Elevated 12-lipoxygenase mRNA expression correlates with advanced stage and poor differentiation of human prostate cancer. , 1995, Urology.

[210]  A. Mantovani,et al.  Membrane fluidity affects tumor‐cell motility, invasion and lung‐colonizing potential , 1989, International journal of cancer.

[211]  J. Bockaert,et al.  NMDA receptors activate the arachidonic acid cascade system in striatal neurons , 1988, Nature.

[212]  A A Spector,et al.  Membrane lipid composition and cellular function. , 1985, Journal of lipid research.